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Abstract

As the field of functional genetics and genomics is beginning to mature, we become confronted with new challenges. The constant drop in price for sequencing
and gene expression profiling as well as the increasing number of genetic and genomic variables that can be measured makes it feasible to address more complex
questions. The success with rare diseases caused by single loci or genes has provided us with a proof-of-concept that new therapies can be developed based on
functional genomics and genetics.
Common diseases, however, typically involve genetic epistasis, genomic pathways, and proteomic pattern. Moreover, to better understand the underlying biological systems, we often need to integrate information from several of these sources.
Thus, as the field of clinical research moves toward complex diseases, the demand
for modern data base systems and advanced statistical methods increases.
The traditional statistical methods implemented in most of the bioinformatics
tools currently used in the novel field of genetics and functional genomics are
based on the linear model and, thus, have shortcomings when applied to nonlinear biological systems. The previous work on partially ordered data (Wittkowski
1988; 1992), when combined with theoretical results (Hoeffding 1948) and computational strategies (Deuchler 1914) has opened a new field of nonparametric
statistics. With grid technology, new tools are now feasible when screening for
interactions between genetics (Wittkowski, Liu 2002) and functional genomics
(Wittkowski, Lee 2004).

Having more complex study designs and more specific methods available increases the demand for decision support when selecting appropriate bioinformatics tools. With the advent of rapid prototyping systems for Web based database
application, we have recently begun to complement previous work on knowledge
based systems with graphical Web-based tools for acquisition of DESIGN and
MODEL knowledge.
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1 Introduction
As the field of functional genetics and genomics is beginning to mature, we become confronted with new
challenges. The constant drop in price for sequencing
and gene expression profiling as well as the increasing
number of genetic and genomic variables that can be
measured makes it feasible to address more complex
questions. The success with rare diseases caused by
single loci or genes has provided us with a proof-ofconcept that new therapies can be developed based on
functional genomics and genetics.
Common diseases, however, typically involve genetic
epistasis, genomic pathways, and proteomic pattern.
Moreover, to better understand the underlying biological systems, we often need to integrate information
from several of these sources. Thus, as the field of
clinical research moves toward complex diseases, the
demand for modern data base systems and advanced
statistical methods increases. At the same time, as with
many emerging fields, better understanding of the underlying concepts allows for similarities with other,
more established fields to be revealed and, thus, some
of the techniques developed earlier to be revisited.
As biological systems are often controlled by a variety
of regulatory feedback loops, many of which may be
unknown, the assumption that the functional form of
the relationship between a measurement and activity or
efficacy is known may not be valid, except, at best,
within very narrowly controlled experimental settings.
Since twenty years ago (Wittkowski 1980), new nonparametric methods have been developed to avoid
artifacts created by using methods based on unrealistic
assumptions. New bioinformatics tools now help to
make these methods more widely available. The earlier
work introduced the marginal likelihood principle
(MrgL) as a technique to extend rank tests to partially
ordered univariate data, in general, and missing data,
in particular (Wittkowski 1980; 1984; 1988b; 1988e).
From extensive consulting experience, it soon was realized that few biological systems can be sufficiently
characterized by a single variable only. In 1992, rank
2009-12-08

tests for censored data were generalized to multivariate ordinal observations (Wittkowski 1992a). While
this approach proved eminently useful (Einsele, Ehninger 1995; Susser, Desvarieux 1998; Talaat,
Wittkowski 1998; Wittkowski, Susser 1998), the computational effort that comes with the MrgL principle
was prohibitive. Only after drawing on the analogy of
the Mann-Whitney (u statistics) and the Wilcoxon test
(MrgL), a more computationally efficient approach
became available, this time based on u-statistics
(Hoeffding 1948) and a computational strategy that
had been earlier devised in Tübingen (Deuchler 1914),
see, e.g., (King, Jim 2003)
Recently, we have begun to extend this approach by
allowing for more complex designs in genetics
(Wittkowski, Liu 2002; Wittkowski, Liu 2004) and
more problem-specific partial orderings (Wittkowski
2003). The first Web tools based on these results are
now available (muStat.rockefeller.edu). For small data
sets, spreadsheets can be downloaded, for larger data
sets, we are moving parallelized computational services from a cluster to a grid.
As the complexity of experimental designs and the
choice of statistical methods increases, so does the
need for data management and decision support. The
PANOS system (Wittkowski 1985) provided for the
first data model and a knowledge representation
concept able to support the choice of both parametric
and non-parametric methods. A subset of these results
can be seen in JMP (SAS Institute Inc. 2002). More
recently, we developed a similar data model for topological (genetics) and functional relations (genomics)
between variables (SNPs and genes, respectively) to
be represented.
As with many knowledge based systems, knowledge
acquisition remained a bottleneck. Drawing upon
modern rapid prototyping systems, we have now begun to implement a Web based tool for acquisition of
knowledge on the biological background and the experimental design (WISDOM).
1
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2 U Statistics for Changes in Function
Complex diseases are typically characterized by several variables. In Phase I/II studies, were surrogate activity variables need to be considered in lieu of clinical
outcomes, it is especially unlikely that a single variable can be found to be sufficient. With traditional linear weight scoring systems, one transforms each variable individually (linear, logarithmic, categorization)
to obtain a score on a comparable scale (present / absent, low / intermediate / high, 1 to 10, z-score) and then
defines a global score as the linear combination
(weighted average) of these individual scores.
Relying on the linear model has advantages. First, algorithms are computationally efficient. Mean and standard deviation, for instance, are easily computed with
a pocket calculator, while quartiles, the analogues
based on u statistics, are not. Second, the assumption
of independent, additive main effects and interactions
coerces fitted models whose alluring simplicity often
turns out to be an artifact of the linear model not easily
allowing for more complex, non-linear relations. Finally, the assumption of independent additive errors
yields the convenient bell shaped distribution of errors.
The prayer that biology be linear, independent, and
additive, however, is rarely answered and the central
limit theorem does not provide for a rescue from
model misspecification. In particular, the relative importance of the variables, and, thus the weight they
need to be assigned, is typically not known a-priori.
Since relative importance, correlation, and functional
relationship between variables are typically unknown,
construct validity (Cronbach, Meehl 1955) cannot be
established on theoretical grounds. Instead, researchers
often resort to empirical ‘validation’, choosing weights
and functions that provide a reasonable fit with a ‘gold
standard’ when applied to a sample. While this allows
for a comparison between studies where researchers
agreed on the same scoring system, comparability
along a scale with questionable validity may still yield
questionable results. The diversity of scoring systems
used attests to their subjective nature.
Recently, we have utilized multivariate u statistics to
overcome these obstacles, providing the first approach
generating clinical scores that are ‘intrinsically valid’,
i.e., that do not need to rely on empirical validation, a
process of questionable validity by itself (Popper
1937). While this approach proved eminently useful,
we soon realized that further work was needed, because additional information about relationships between the variables often needs to be reflected.

Within the linear model, multivariate data can be reduced to a score by applying a simple transformation
such as the average, difference, or ratio. In other cases,
one estimates a more complex parameter, like the
slope of a regression line or a maximum likelihood estimate. If one does not feel comfortable with the assumptions of linearity and independence underlying
the linear model u statistics can provide solutions for
closely related questions. For univariate data, the Wilcoxon-Mann-Whitney u test (Mann, Whitney 1947;
Wilcoxon 1954), for instance, corresponds to the Student t-test (Student 1908). The question then arises,
how to extend u statistics to reflect known relations
between variables. Interestingly, one of the first application of multivariate u statistics, the u-test for (interval) censored data (Gehan 1965a; 1965b; Schemper
1983) can be seen as a u-test for bivariate data, if one
replaces the natural partial ordering (Wittkowski, Lee
2004, Eq. 1) by a specific ordering, where intervals are
ordered, if they are disjoint (non-overlapping).
Ratio

<

>

Difference

Fig. 1: Changes (indicated by vertical arrows) that can be ordered
for differences and ratios. Changes to the left or right of the reference (center, bold) are smaller or larger, respectively, than the reference. By the partial ordering for intervals, in contrast, only the
three arrows to the left are higher than the three arrows to the right.

We have recently developed additional partial orderings (see, e.g., Fig. 1). To some extent, differences
(e.g., changes over time), are the ‘opposite’ of intervals, in that they can be unambiguously ordered only if
one ‘interval’ is fully contained in the other, rather
than disjoint. Obtaining pair wise orderings of ratios
(e.g., changes in concentration) can be obtained under
the same conditions, but ratios can also be ordered if
the change at the lower level (distance from zero) is at
least as large as the change at the higher level.
To better reflect specific problems in genetics and
genomics, we will develop more partial orderings,
thereby making multivariate u-statistics more
widely applicable.
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3
3.1

U Statistics for Microarrays
Quality Control

U statistics have various applications in functional genomics. At a low level, quality of data scanned from a
microarray (Fig. 2a) can be affected by a plethora of
potential confounders, which may act during printing,
manufacturing, hybridization, washing, and reading.
Given the high probe-to-probe variance and their random allocation on the chip, it is impossible to visually
detect all but the starkest artifacts.
As the price for chips drops, a typical experiment now
contains several chips, each representing a sample obtained under conditions that were similar except for
the experimental factor under investigation. This offers
new strategies for testing the effect of the experimental
factor, e.g., through ‘robust multiarray analysis’
(Irizarry, Hobbs 2003). As probes differ in affinity
(Naef, Magnasco 2003; Wu, Irizarry 2004), their correlation can also be used to identify small blemishes.

Having substantially improved quality control of
high density oligonucleotide arrays, we will finetune the pattern recognition process, to reduce the
number of parameters, increase sensitivity for specific types of blemishes, and to allow for more complex, factorial designs.

raw image

A tool to detect blemishes automatically (Fig. 3c) is
available at asterion.rockefeller.edu/Harshlight. While
the first version (Suárez-Fariñas, Haider 2005) was
based on traditional pattern recognition methods, with
several parameters to be chosen, we are now working
on replacing this linear model approach, too, by a nonparametric approach based on u-statistics.

Fig. 3: Left (a): Raw image file detail of the ‘dark spot’ artifact
seen in the center of Fig. 2. Right (b): Raw image file detail of the
the ‘bright spot’ in the top right corner of Fig. 2.

average

The choice of the arithmetic mean (average) as the
measure of central tendency in linear models relies either on the law of large numbers and the central limit
theorem or on the assumption that the distribution of
errors at least symmetrical. Here, neither assumption is
easily justified. Fig. 4 demonstrates that median filtering, based on u-statistics, causes less ‘ghosting’ than
average filtering, based on the linear model.

Fig. 2: Top (a): upper 50% pseudo-image of a HuU95av2 chip.
Bottom (b): median filtered image (3 chips). (c) HarshLight mask

median

Fig. 2b exhibits a variety of such blemishes. The shadowy circle on the left side, e.g., is clearly an artifact, as
are the bright spot in the upper-right corner, and the
dark spot in the upper center (Fig. 3). These examples
are based on U95 chips with 16 probe pairs per probe
set. On U133 chips, with only 11 pairs per set, the effect of artifacts on results is expected to increase.

Fig. 4: The artifact of Fig. 3b. Top: raw image from the same area
of two chips showing gene expression from the same sample under
two experimental conditions. Center: average filtering, bottom:
median filtering.
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Within each probe set, one then selects the pair with a
score of zero as the most ‘typical’, or, if necessary, the
weighted average among those closest to zero (Fig. 5).
As this guarantees ‘outliers’ to be excluded, the alleged need for taking logarithms has been overcome.
Requesting that this estimate be non-negative results in
a much smaller bias than decreasing xk,MM for each pair
where xk ,PM < xk ,MM (Haider, Naef 2003).
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Fig. 5: Signal value estimation with u-statistics. The u scores for
probe pairs closest to the median are displayed in white.

9
7
5
4
3
2

1039

mSVE

7
5
4
3
2

1029
7
5
4
3
2

1019
7
5
4
3
2

1008

Bias

}

< xk ′,PM ) ∧ ( − xk ,MM < − xk ′,MM )

0
0
0
0
0
-1
-1
-1
-1
-1
-1
-1
-1
-1
-1
-1

0.52 -0.06

{( x

-0.09
-0.13
-0.73
-0.06
-1.03
-0.61
-1.07
-1.06
-0.21
-0.29
-0.56
-0.99
-1.67
-2.14
-0.93
-1.83

1.71 -0.73

< xk ′ } ⇔

PM d3 -MM
1.29
1.35
1.71
0.52
1.54
0.60
1.24
0.69
0.22
0.23
0.45
0.59
1.16
0.93
0.18
0.57

1.35 -0.13

{ xk

d1

1.29 -0.09

3.2 Signal Value Estimation
To estimate the non-specific portion of the binding on
an Affymetrix GeneChip®, each ‘perfect match’ (PM)
is paired with a ‘mis-match’ (MM), with the middle
nucleotide exchanged for its WATSON-CRICK complement. When estimating the signal value for a particular
gene from a probe set of pairs of perfect and mismatches, several parametric and semi-parametric (‘robust’) methods have been proposed.
To allow for a linear model to be based on the logarithms of the differences, it has been suggested
(Hubbell, Liu 2002) to artificially decrease xMM of
probe pairs where xPM < xMM to a heuristically motivated level that ensures that xPM − xMM is positive. As a
justification for this ‘background correction’, it is argued that a mismatch should never be higher than a
perfect match. For genes that are not expressed in the
biological sample, however, one would expect 50% of
the pairs to have higher mis- than perfect matches.
Then, this ‘correction’ creates a bias, because estimates for genes with expression level zero have signal
value estimates as high as genes with low, but positive
expression levels, the level of this estimate depending,
in part, on the within-probe variance.
Above, the need for various partial orderings has been
stressed. When using u statistics, this bias can easily
be overcome by employing the following partial ordering for signal value estimation:

10-2.00

10 -1.00

100.00

101.00

10 2.00

10 3.00

104.00

uSVE

Fig. 6: MAS 5.0 bias for genes with low expression levels. Probes
with u statistic signal value estimates ≤0 are scattered around 10-2

Again, more steps lie ahead. Even after reducing the
effect of blemishes, the large differences in affinity
between PM probes can render the order of many
probe pairs ambiguous. Drawing on the sequence
information (Naef, Magnasco 2003), in addition to
eliminating blemishes, should further improve the
reliability of signal value estimates.

Bias

Fig. 5 shows a spreadsheet implementation of u statistics for probe sets. Fig. 6 and Fig. 7 depict the bias for
a chip from the study mentioned earlier and for the
‘spike-in’ data set (Irizarry, Hobbs 2003), respectively.

Fig. 7: MAS 4.0, MAS 5.0, and U-statistics – bias vs. variance stabilization, log2 transformed axes.
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3.3 Gene expression profiling
Once a signal value estimate has been obtained for
each gene, u statistics for gene expression profiles are
conceptually not different from u-statistics for clinical
response profiles, although the computational complexity is higher, because neither the subset of relevant
genes nor their ‘orientation’ is known a-priori. In one
of our first applications (Wittkowski, Lee 2004), we
started with scoring clinical response (disease severity)
based on several outcomes. As is typical for assessing
phenotypes, both the set of variables and their orientation was known. For each outcome (epidermal thickness, K16 histology), it was reasonable to assume that
‘more’ was ‘worse’ (more inflammation). In the second step, we then looked for the set of genes most
closely related to the effect of the drug given on the
phenotype score. As is typical for screeing in functional genomics neither the set of genes involved, nor
their orientation (sign of the correlation with the phenotype) was known.
The foundation of a solution sufficiently efficient for
genomic screening was laid in 1989 (Wittkowski
1989), when the need for distinguishing between ‘exact ties’ (complete ordering) and ‘inexact ties’ (partial
ordering) was identified. By applying the distinction
between the conditional and the unconditional variance (Wittkowski 1988b) to this special case of a
stratified rank test, it was demonstrated that both versions of the sign test (Dixon, Mood 1946; Dixon,
Massey 1951) were valid, albeit for different situations, thereby resolving the long-felt discomfort with
the treatment of ties in the McNemar test (McNemar
1947) when applied to rounded data. These results
have subsequently been independently confirmed
(Rayner, Best 1999; Randles 2001; Fong, Kwan 2003)
see also (Wittkowski 2004).
Recently, we have made several major advantages in
computational efficiency. First, as mentioned above,
we moved from the marginal likelihood (MrgL) to ustatistics. While the computational effort of generating
all rank permutations rises with the factorial of the
sample size (n!), the computational effort for ustatistics rises only with the square of the sample size
(n2). This computational simplicity allowed us to increase the number of subjects that could be scored to
32 while using a spreadsheet as the first implementation and a didactical tool (see, e.g., Fig. 5). While the
spreadsheet was highly appreciated for visualizing the
algorithm underlying u-statistics, manual screening
among all possible polarized subsets is impractical.

To overcome these limitations, the next implementation of the method was written in S-Plus (Insightful
Corp.). While S-Plus provides for a convenient environment to implement statistical methods at a high
level, some operations, notably ‘for loops’, cannot be
represented efficiently. Thus, we developed a library of
C subroutines to increase the computational efficiency,
while keeping higher level tasks in S-Plus to allow for
easy adaptation to various experimental designs and
partial orderings. With these optimizations, the approach became sufficiently efficient for a limited
number of variables. The software has recently contributed to gaining new insights into the genetic and
genomic determinants of atherosclerosis (Dansky, Ono
2001; Smith, James 2003), cancer susceptibility
(Banchereau, Palucka 2001; Palucka, Dhodapkar
2003), allergology (King, Jim 2003), psoriasis (Lowes,
Lin 2004), and addiction (Spangler, Wittkowski 2004).
While this provided for a proof-of-principle, we soon
realized that a single processor system would not be
sufficient to fulfill the growing demands of our investigators. To increase the throughput, we parallelized
the software and then sought collaboration from the
RU Information Technology department to run the software on a multiprocessor cluster. To make this tool
more widely available, we then provided access
through a Web server (mustat.rockefeller.edu).
Moving from a desktop to a multiprocessor cluster
demonstrated the scalability of the problem, but the
feedback from our clinical investigators immediately
indicated the need for further increases in computational efficiency. As the next step, we have begun to
migrate from the 8-processor cluster to a ≈100processor grid.
Not all analytical tasks are equally easy to distribute
across a grid. In some cases, it may turn out that for
several task to share intermediate results may provide a computational advantage, so that it would be
preferable to run certain tasks on a cluster of processors having joint local access to the same data.
We will then separate these tasks from those being
distributed throughout the grid and have them
routed to the cluster.
Finally, we anticipate that a multiprocessor architecture may be not optimal for all tasks, but that some
task would benefit from dedicating specific hardware. For such tasks, we are currently exploring the
possibility to equip dedicated servers with field
programmable gate arrays (FPGA).
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4 U Statistics in Genetics
Associations between genetic risk factors and clinically relevant phenotypes were first sought by means
of simple χ2 statistics comparing allele prevalence between cases and controls. To better deal with confounding through population admixture, an analytic
approach was suggested, termed ‘transmission disequilibrium test’ (TDT) (Spielman, McGinnis 1993) that
would allow to correct for confounding by obtaining
the genotypes from cases and their parents, rather than
from cases and controls. Over 10 years, this landmark
paper has been cited more than 1500 times, making the
TDT one of the most frequently used analytic approach in the field of genetics. Still, the TDT was
never presented with the formal rigor that had evolved
in the field of statistics, although it was thought to be a
sign test (Dixon, Massey 1951) or McNemar (1947)
test for data with exact ties (Wittkowski 1998;
Wittkowski 2004). Instead, the TDT was heuristically
motivated using genetic terminology, which led to the
belief that independence of transmission events (genetics) implied independence of the observations (statistics). In 2002 (Wittkowski, Liu), we separated the statistical theory from the genetic application, thereby
demonstrating that children should be stratified according to the parental mating type using standard statistical methodology for stratified non-parametric tests
(Wittkowski 1988b). The resulting stratified McNemar
(SMN) test proved to be superior to the TDT in many
ways and the discussion shed light on the heuristics
underlying the TDT (Wittkowski, Liu 2004).
In particular, the new insight into the nature of this approach now allows for generalizing the family of TDTlike tests. For instance, the power of the TDT and, albeit to a lesser extend, of the SMN, is unsatisfactory
for alleles with either both low prevalence (frequency)
and low dominance ( r(aA) ≈ r(aa) ) or with both high
prevalence and high dominance ( r(aA) ≈ r(AA) )
(Goddard, Wittkowski 2003).
To further improve statistical tests for association
based on trios, we will compare different variants of
the SMN through simulation studies to find tests
with either uniformly higher power across different
levels of dominance or, alternatively, with power
characteristics optimized to detect alleles with either
low or high dominance. Then, we will extend the
methodology from binary to ordinal outcomes (as in
the qTDT) and then, as a direct consequence, to
multivariate ordinal outcomes (as a novel “uTDT”).

As yet another direction for development, our investigators requested a more flexible tool, where information from neighboring marker loci is integrated to
identify a disease locus. For inbred populations, all
possible diplotypes coincide with the haplotypes, so
that ‘marker intervals’ can be easily ordered (Fig. 8a).
For outbred populations, however, the partial ordering
can be more complicated (Fig. 8b). The need for a special partial ordering arises from the specific meaning
of the term ‘interval’ in this context.
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Fig. 8: Partial orderings of genetic evidence for an interval between two markers to contain a disease gene G, left: inbred strains,
right: outbread strains. Nodes within boxes are comparable only
with nodes connected through a dashed line or through the lines
connecting the box, but not among each other.

In one of our first applications (Sehayek, Yu 2004),
this new approach let to identifying synteny of a human locus with a ‘high plant sterol allele’ on chromosome 20 to the mouse locus Plast2b on distal chromosome 2 (Sehayek, Duncan 2002). As the number of
SNPs available for analysis increases, several adjacent
SNPs may be in linkage disequilibrium with a diseases
locus. Moreover, a phenotype may be associated with
an ‘epistatic set’ of diplotypes being several markers
apart, or even on different chromosomes (Gambis, Sehayek 2003). Zwei weitere aktuelle Anwendungsgebiete sind die Identifikation genetischer Faktoren bei olfaktorischen Störungen (Leslie Voshall) und bei polycystic kidney diseases (Rogosin Institute).
From our experience, the next steps are (a) to extend the partial ordering for marker intervals to a
partial ordering for diplotypes consisting of more
than two neighboring SNPs and (b) to extend the
default partial ordering of epistatic SNPs to one that
allows for epistatic diplotypes.
As u statistics can easily integrate SNP and gene
expression data in a single analysis, the above extensions will allow complex interactions between
genetic and functional genomic to be addressed.
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tween different observations, the latter describes the
variables’ known characteristics, that are relevant for
choosing statistical methods, in general, and statistical
graphics (Wittkowski 1983), in particular: scale level
(nominal < ordinal < interval < absolute), accuracy (exact, rounded), granularity (2 … ∞), and causality (stratum < intervention < observation).
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When we developed the current server for ‘multivariate u Statistics’ (muStat.rockefeller.edu), we faced a
different problem. The PANOS data model had focused on multifactorial designs with univariate observations. The muStat data model, in contrast, was initially restricted to elementary statistical methods:
product moment correlation (ordinal phenotype), 2sample t-test (binary phenotype). With the focus on
multivariate data in genetics and genomics, the model
incorporates two additional features. First, the location
of the SNPs is formally described to allow the statistical methods to build upon our understanding of the
correlation between adjacent loci (linkage). Second, as
it is often not known whether a particular allele and
gene increases or decreases risk, the polarity of a variable could be declared as unknown (‘0’), in addition to
‘1’ or ‘-1’. For genetic information, one might want to
separate chromosomes further into exons or even
genes. For genomic (or proteomic) information, one
might want to group genes into known functional pathways.
IntrVntn

5 Data Models
A suitable data model is crucial for the ease by which
biostatistics and bioinformatics tools can interact with
users and among themselves. Making a tool for the
analysis of complex designs available for a large group
of users using different data base and analysis systems
while having limited knowledge in statistics and/or informatics requires data models that are rich enough to
represent necessary information, yet simple enough to
be easily communicated.
For small data sets and simple statistical methods, it is
often sufficient to store data in a single table, e.g., as a
spreadsheet. In functional genomics, however, data is
frequently associated to different objects. Some variables (e.g., SNPs) are measured once per subject,
while others (e.g., gene expression) are measured repeatedly, under different conditions. Storing data in a
universal relation (single table), is convenient for data
retrieval and inspection, but repeating genetic information for every gene expression profile poses problems
for statistical analyses (Wittkowski 1988d), as the
number of genetic observations could be seen a inflated by the number of genomic conditions. Of
course, this dilemma could be avoided by requiring
data to be transmitted in third normal form (3NF),
where redundancy is avoided (Codd 1970). This, however, would require that the user decomposes the familiar universal relation into a set of 3NF relations, the
number of such relations depending on the particular
study design. Still, not all relevant design characteristics are easily represented in the relational data model.
To guide the selection of appropriate statistical methods, for instance, it is important to distinguish completely randomized designs, where the first patient in
group A bears no similarity to the first patient in group
B, from a matched pair design, where the first patient
in group A is the sibling of the first patient in group B.
The increasing volume of data and the diversity of statistical methods create new challenges in data management. As part of the ‘PArametric and NOnparametric
Statistics’ (PANOS) project (Wittkowski 1985), a data
model was presented that allowed for data to be represented in the familiar form of a universal relation,
while includingthe first representation of meta data
(‘knowledge’) sufficient to guarantee semantically
meaningful statistical analyses. This knowledge was
then structured into different layers, among them the
DESIGN and MODEL layers (Elliman, Wittkowski
1987; Wittkowski 1987; 1992b; 1993). The former
specifies the data structure, i.e., the logical relation be-
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76 22 156 2.1 156 2.05

Fig. 9: Draft proposal for a unification of the PANOS and the
muStat data model. The rows in the block ‘hierarchical variable
structure’ provide information necessary to generate a 3NF relation
by adding additional keys/factors and ‘stacking’ variables.

To overcome the deficiencies of traditional data
models when representing relevant relationships between variables, we propose to define a ‘factorial’
structure not only for the subjects, but also for the
variables. This structure should be hierarchical, to
allow for step-by-step refinement of topological
structures (chromosome, intron, gene, SNP) or logical structures (ontology group, pathway, gene).
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6 Knowledge Acquisition
The PANOS system (Wittkowski 1985) focused on
how best to choose statistical methods, but shared a
feature of many previous ‘knowledge based’ systems:
It did not yet include a sufficiently user-friendly
(DESIGN) knowledge acquisition module. Thus, when
the results were commercialized by SAS, Inc. in 1989
as JMP, only a small portion of DESIGN knowledge
was incorporated.
As new technologies become available we are now
working on a prototype of a graphical user interface,
where clinical trials, genetic studies, or gene expression experiments can be described interactively in sufficient detail to extract DESIGN knowledge. Fig. 10
shows an example based on one of our ongoing studies
on cardiovascular and metabolic diseases (with the RU
Laboratory of Biochemical Genetics and Metabolism).

Fig. 10: Screen shot from the Web-based Interactive Study Design, Operation, & Management (WISDOM) module: Patients are
first randomized to two diets (low carb vs low fat) and then, within
each diet to two hormones (leptin vs placebo). During Visit_4,
Heart function is evaluated in a factorial design.

Allowing for information on genetic epistasis, genomic pathways, and proteomic profiles to be combined
for statistical analysis requires even more meta data to
be added to data models (see Section 5. Data Model).
The analysis system needs to be able to differentiate
between different partial orderings (see Section 2. U
Statistics for Changes in Function), to employ appropriate screening strategies (see Section 3.3. U Statistics
for Microarrays: Gene expression profiling), to consider topological and functional relations between
variables (see Section 4, U Statistics in Genetics).
Having a sufficiently rich formal description of experimental designs available has a number of advantages, each of which typically draws on a different
view of the knowledge base. In particular, the
DESIGN knowledge base can be used to facilitate
database creation, by automatically setting up a (relational or object-attribute-value) database,
sample size calculations, by allowing to simulate
power for complex designs,
protocol writing, e.g., by generating pre-populated
protocol templates for NIH’s ProtoType system,
security, by facilitating the use of centralized servers,
thereby reducing the need for decentralized storage, e.g., as spreadsheets on various PCs,
study management, by generating “pathways” providing nurses with workflow information,
data entry, by generating case report forms, either on
paper or as Web interfaces,
monitoring, by allowing software to automatically
screen for adverse event profiles and alerting data
and safety monitoring boards based on preset criteria, if necessary,
inspection, by giving investigators real-time information while automatically protecting them from becoming accidentally unblinded,
review, by providing the Institutional Review Board
with progress information.
analysis, by storing primary and secondary objectives
and automatically initiating the appropriate analyses according the protocol,
data sharing, by providing standardized dictionaries,
allowing data to be related across studies.
Thus, to facilitate use of the new statistical methods
and analytical tools in genetics, functional genomics, and proteomics, we will continue to work with
investigators, computer scientists, and statisticians
on integrating knowledge acquisition modules and
knowledge based analysis tools.
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7 Summary
The traditional statistical methods implemented in
most of the bioinformatics tools currently used in the
novel field of genetics and functional genomics are
based on the linear model and, thus, have shortcomings when applied to nonlinear biological systems. The
previous work on partially ordered data (Wittkowski
1988b; 1992a), when combined with theoretical results
(Hoeffding 1948) and computational strategies
(Deuchler 1914) has opened a new field of nonparametric statistics. With grid technology, new tools are
now feasible when screening for interactions between
genetics (Wittkowski, Liu 2002) and functional genomics (Wittkowski, Lee 2004). We will continue the
ongoing collaborative efforts in broadening the spectrum of partial orderings to meet the demands of more
complex study designs and to make these bioinformatics/biostatistics tools available over the Web.
Having more complex study designs and more specific
methods available increases the demand for decision
support when selecting appropriate bioinformatics
tools. With the advent of rapid prototyping systems for
Web based database application, we have recently begun to complement my previous work on knowledge
based systems (Wittkowski 1985; 1988c; 1988a; 1991;
1993) with graphical Web-based tools for acquisition
of DESIGN and MODEL knowledge. To make the
biostatistics tools more widely available and more easily accessible, we will continue to improving data base
design and knowledge acquisition tools for clinical trials, in general, and for functional genomics and genetics, in particular.
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